PHARMA
JHL Biotech, Selexis SA Provide Speedy Drug Manufacturing Services
JHL Biotech and Selexis SA are collaborating to provide a seamless solution for the development and cGMP manufacturing of biologic drugs.
NovaBay, China Pioneer Pharma To Co-Market Products
NovaBay Pharma has partnered with China Pioneer Pharma to market its products in China and 11 countries in Southeast Asia.
SIMM, Crown BioScience To Build Mouse Xenograft Model Center
Shanghai Institute of Materia Medica and Crown BioScience, Inc. have agreed to jointly build a mouse clinical trial center in China.
Singapore-Japanese Tie-Up On Biotech Innovation
A Japanese-Singapore collaboration will focus on the R&D and commercialization of novel clinical approaches for diseases relevant to the Asian population.
Takeda’s Oral Proteasome Inhibitor MLN9708 Enters Ph III Study In Japan
Takeda has initiated enrollment of patients in Japan in an ongoing global Phase III clinical study of its novel oral proteasome inhibitor MLN9708.
Mallinckrodt, China Resources Pharma To Promote Optiray X-Ray
Mallinckrodt Pharmaceuticals has partnered with China Resources Pharma to promote its Optiray™ (ioversol injection) x-ray contrast media in China.
Medifocus, Ideal Concept JV To Market Prolieve Treatment
Medifocus has entered into a joint venture agreement with Ideal Concept Group to sell and market its Prolieve treatment in China and other Asian countries.
Merck Invests €80 Million On Pharmaceutical Facility In China
Merck has invested €80 million into a new pharmaceutical manufacturing facility to be located in the Greater Shanghai region, China.
Eli Lilly Funds US$350 Million To Expand Insulin Production In China
Eli Lilly and Company will invest US$350 million to expand its insulin cartridge manufacturing capacity in China.
